Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer

BJU International

Volumn 107, Issue 11, 2011, Pages 1825-1832

  Salinas Sánchez, Antonio S ^a,b   Sánchez Sánchez, Francisco ^a   Donate Moreno, María J ^a   Rubio Del Campo, Antonio ^a   Gimenez Bachs, José M ^a   Lorenzo Romero, Juan G ^a   Serrano Oviedo, Leticia ^a   Escribano, Julio ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b Urology Department   (Spain)

Author keywords

bladder tumour; glutathione S transferase; GSTM1; GSTT1; prognosis

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NULL ALLELE; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING HABIT; SPAIN;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROGNOSIS; REFERENCE VALUES; SEX DISTRIBUTION; URINARY BLADDER NEOPLASMS;

EID: 79956360359     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09683.x     Document Type: Article

References (39)

1. Urrutia G, Serra C, Bonfill X, Grupo BR,. Trabajo para el Estudio del Cáncer de Vejiga Urinaria en la Comarca del Vallés Occidental. Incidencia del cáncer de vejiga urinaria en un área industrializada de España. Gac Sanit 2002; 16: 291-7
2. Viscoli CM, Lachs MS, Horwitz RI,. Bladder cancer and coffee drinking: a summary of case-control research. Lancet 1993; 341: 1432-7 (Pubitemid 23161444)
3. Kunze E, Chang-Claude J, Frentzel-Beyme R,. Life style and occupational risk factors for bladder cancer in Germany. A case-control study. Cancer 1992; 69: 1776-90
4. Brockmöller J, Cascorbi I, Kerb R, Roots I,. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996; 56: 3915-25 (Pubitemid 26284739)
5. Silverman DT, Rothman N, Devesa SS,. Epidemiology of bladder cancer. In, Syringos KN, Skinner DG, eds, Bladder Cancer. Biology. Diagnosis. Management, New York: Oxford University Press Inc, 1999: 11-55
6. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW,. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85: 1159-64 (Pubitemid 23212283)
7. Vineis P,. Epidemiology of cancer from exposure to arylamines. Environ Health Perspect 1994; 102 (Suppl. 6): 7-10 (Pubitemid 24364870)
8. Hemelt M, Yamamoto H, Cheng KK, Zeegers MP,. The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer 2009; 124: 412-9
9. Boffetta P,. Tobacco smoking and risk of bladder cancer. Scand J Urol Nephrol Suppl 2008; 218: 45-54
10. Eaton DL, Bammler TK,. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999; 49: 156-64 (Pubitemid 29300401)
11. Strange RC, Fryer AA,. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ 1999; 148: 231-49
12. Rebbeck TR,. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997; 6: 733-43 (Pubitemid 27427630)
13. Raunio H, Husgafvel-Pursiainen K, Anttila E, Hietanen E, Hirvonen A, Pelknonen O,. Diagnosis of polymorphisms in carcinogen-activating and in activating enzymes and cancer susceptibility-a review. Gene 1995; 159: 113-21
14. Roots I, Brockmoller J, Drakoulis N, Loddenkemper R,. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients. Clin Investig 1992; 70: 307-19
15. Perera FP,. Environment and cancer: who are susceptible? Science 1997; 278: 1068-73 (Pubitemid 27517877)
16. Pemble S, Schroeder KR, Spencer SR, et al,. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300 (Pt 1): 271-6 (Pubitemid 24151046)
17. Seidegård J, Pero RW, Miller DG, Beattie EJ,. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis 1986; 7: 751-3 (Pubitemid 17130636)
18. Landi S,. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000; 463: 247-83
19. Salagovic J, Kalina I, Stubna J, et al,. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Neoplasma 1998; 45: 312-7 (Pubitemid 29010681)
20. Lee CK, Cho SH, Kang JW, et al,. Comparison of three analytical methods for 1-hydroxypyrene glucuronide in urine after non-occupational exposure to polycyclic aromatic hydrocarbons. Toxicol Lett 1999; 108: 209-15
21. Brockmöller J, Kerb R, Drakoulis N, Staffeldt B, Roots I,. Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Res 1994; 54: 4103-11 (Pubitemid 24258116)
22. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK,. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993; 14: 1821-4 (Pubitemid 23290894)
23. United Nations Statistics Division. International Industrial Classifications of All Economics Activities. (ISIC Rev 3.1). ST/ ESA/ STAT/SER.M/4/ Rev 3.1. 2002.
24. Garcia-Closas M, Malats N, Silverman D, et al,. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005; 366: 649-59 (Pubitemid 41176017)
25. Johns LE, Houlston RS,. Glutathione S-transferase mu1(GSTM1) status and bladder cancer risk: a meta-analysis. Mutagenesis 2000; 15: 399-404
26. Song DK, Xing DL, Zhang LR, Li ZX, Liu J, Qiao BP,. Association of NAT2, GSTM1, GSTT1, CYP2A6 and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in central China. Cancer Detect Prev 2009; 32: 416-23
27. Rouissi K, Ouerhani S, Marrakchi R, et al. Combined effect of smoking and inherited polymorphism in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genet Cytogenet 2009; 190: 101-7
28. Yuan JM, Chan KK, Coetzee GA, et al,. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Carcinogenesis 2008; 29: 1386-93
29. Hung RJ, Boffetta P, Brennan P, et al,. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high risk population. Int J Cancer 2004; 10: 598-604 (Pubitemid 38658026)
30. Moore LE, Wiencke JK, Bates MN, Zheng S, Rey OA, Smith AH,. Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 2004; 211: 199-207 (Pubitemid 38824633)
31. Board P, Harris M, Flanagan J, Langton L, Coggan M,. Genetic heterogeneity of the structure and function of GSTT2 and GSTP1. Chem Biol Interact 1998; 111-112: 83-9 (Pubitemid 28271936)
32. Srivastava DS, Mishra DK, Mandhani A, Mittal B, Kumar A, Mittal RD,. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 2005; 48: 339-44 (Pubitemid 40957115)
33. Jong Jeong H, Jin Kim H, Young Seo I, et al,. Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers. Cancer Lett 2003; 202: 193-9
34. Steinhoff C, Franke KH, Golka K, et al,. Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol 2000; 74: 521-6
35. Whalen R, Boyer TD,. Human glutathione S-transferases. Semin Liver Dis 1998; 18: 345-58 (Pubitemid 29011039)
36. Simic T, Mimic-Oka J, Savic-Radojevic A, et al,. Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder. Urology 2005; 65: 1035-40 (Pubitemid 40693018)
37. Berendsen CL, Peters WH, Scheffer PG, Bouman AA, Boven E, Newling DW,. Glutathione S-transferase activity and subunit composition in transitional cell cancer and mucosa of the human bladder. Urology 1997; 49: 644-51 (Pubitemid 27161434)
38. Georgiou I, Filiadis IF, Alamanos Y, Bouba I, Giannkopoulos X, Lolis D,. Glutathione S-transferase null genotypes in transitional cell bladder cancer: a case-control study. Eur Urol 2000; 37: 660-4 (Pubitemid 30255781)
39. Aktas D, Ozen H, Atsu N, Tekin A, Sozen S, Tuncbilek E,. Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. A marker for invasive bladder cancer? Cancer Genet Cytogenet 2001; 125: 1-4 (Pubitemid 32288764)